Stroke Journal

JANUARY 30, 2025

Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics.

Outcomes 40

Outcomes Atrial Fibrillation Heart Failure Tachycardia 40

Stroke Journal

JANUARY 30, 2025

Outcomes were 1 year hospital readmission rates by all-cause and due to repeat stroke.Results:Patients in the intervention group and control group were similar in age, BMI, race, smoking status, as well as rates of hypertension, diabetes, hyperlipidemia, atrial fibrillation, and history of prior stroke, with the exception of discharge rate to skilled (..)

Hospital 40

Hospital Strokes Stroke Nursing 40

Circulation

NOVEMBER 11, 2024

The mean BMI was 27.9 One patient had diabetes, 8 had hyperlipidemia, and 9 had hypertension. Only one patient had paroxysmal atrial fibrillation, with a CHA2DS2-VASc score of 0. Of these, 9 (64%) were female with a mean age of 59.6, and 5 (36%) were male with a mean age of 55.4. kg/m2, with 4 classified as obese.

Aneurysm 40

Aneurysm Strokes Stroke Atrial Fibrillation 40

European Journal of Heart Failure

APRIL 13, 2025

BMI, body mass index; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal pro-B-type natriuretic peptide. The beneficial effects of finerenone in patients with heart failure (HF) and mildly reduced or preserved ejection fraction were consistent, regardless of a history of chronic obstructive pulmonary disease (COPD) status.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Pulmonary Peripheral Arterial Disease 40

Open Heart

AUGUST 5, 2022

Objective While greater body mass index (BMI) is associated with increased risk of developing atrial fibrillation (AF), the impact of BMI on outcomes in newly diagnosed AF is unclear. The study population comprised 40 482 participants: 703 underweight (BMI <18.5 kg/m 2 ), 13 095 normal (BMI=18.5–24.9

Atrial Fibrillation 52

Atrial Fibrillation BMI Outcomes Obesity 52

DAIC

JUNE 26, 2024

Semaglutide-mediated improvements in HF-related symptoms and physical limitations were consistent in both male and female participants across key subgroups including age and BMI. It also lowered their systolic blood pressure and waist circumference.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Obesity BMI Heart Failure 105

Stroke Journal

JANUARY 30, 2025

Results:Among the 9,444 participants included, the mean age was 57 (5.7 SD), and 43.2% were men.

Atherosclerosis 40

Atherosclerosis Strokes Stroke Atrial Fibrillation 40